Omaveloxolone

CHEBI:CHEBI_753685

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
2631942
generic_name
Omaveloxolone
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT
listing_expiration_date
20251231
route
ORAL
dosage_form
CAPSULE
active_ingredient_strength
1 kg/kg
nui
N0000187063
pharm_class_moa
Cytochrome P450 2C8 Inducers [MoA]
pharm_class
Cytochrome P450 2C8 Inducers [MoA]
package_marketing_start_date
05-JUL-24
marketing_start_date
20230228
labeler_name
Reata Pharmaceuticals, Inc.
product_ndc
73179-250
spl_id
cf3b636d-1506-443d-b9a3-01c3e5b37b34
active_ingredient_name
OMAVELOXOLONE
package_ndc
73179-250-90
package_description
90 CAPSULE in 1 BOTTLE (73179-250-90)
brand_name
SKYCLARYS
brand_name_base
SKYCLARYS
application_number
NDA216718
manufacturer_name
Reata Pharmaceuticals, Inc.
unii
G69Z98951Q
spl_set_id
f1a1100e-8318-1596-e053-2995a90a533e
upc
1234567890128
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class